Eli lilly trials


















View Pain Trials. Pediatric Research. Kids are not just little adults, and finding new medicines for kids requires specially designed clinical trials. Visit the pediatric research page to learn more. Explore the list of pediatric research areas below designed for kids age 17 or younger or click the button in this section to see a complete list of Lilly clinical trials for kids.

Juvenile Psoriatic Arthritis. Pediatric Cancer. Pediatric Migraine. Pediatric Solid Tumors. Pediatric Uveitis. Systemic Juvenile Idiopathic Arthritis. View Pediatric Trials. Explore the list of research areas for various rheumatology conditions below or click the button in this section to see a complete list of Lilly clinical trials in rheumatology.

Axial Spondyloarthritis Ankylosing Spondylitis. Enthesitis-Related Arthritis. Lupus SLE. Rheumatoid Arthritis. View Rheumatology Trials. Weight Management. Click the button in this section to see a complete list of Lilly clinical trials in weight management. View Weight Management Trials. The video series below provides information about clinical trials, such as how new therapies are developed and how clinical trials are adapting to new approaches in health care.

General Overview of the Clinical Research Process. This animated video is narrated by Dr. Jonathan Jackson, a clinical researcher and clinical trial participant, to describe how new treatments are developed, why people choose to join clinical trials, and more. Basics of Clinical Trial Participation. This animated video describes the basic requirements for all clinical trials, how the safety of study participants is monitored, and how research is adapting in this modern era.

This animated video uses a sports analogy to describe the many different roles of people involved in clinical research, from study participants and their friends and family to the study doctor and study sponsors. Videos used with permission. CISCRP is an independent nonprofit organization focused on educating and informing the public about clinical research participation.

CISCRP is not involved in finding participants for clinical studies and does not conduct clinical research. Clinical trial volunteers make new medicines possible. Take a moment to learn more about what to expect when joining a clinical trial. Click for More. Kids are not just little adults. Want to hear more from people who have joined clinical trials? Interested in exploring innovations in research? In order to learn more about specific clinical trial opportunities, please click the button to find clinical trials at Lilly.

Find a Trial. Explore Lilly Research Areas. Research Areas Did you know that medicines are first tested in clinical trials? Clinical trials help researchers and doctors know whether an investigational medicine works, if it works better in some people than others, and which dose of an investigational medicine will be safe for the people who take it. About Clinical Trials The video series below provides information about clinical trials, such as how new therapies are developed and how clinical trials are adapting to new approaches in health care.

Basics of Clinical Trial Participation This animated video describes the basic requirements for all clinical trials, how the safety of study participants is monitored, and how research is adapting in this modern era.

The Clinical Research Team Is Similar to a Sports Team This animated video uses a sports analogy to describe the many different roles of people involved in clinical research, from study participants and their friends and family to the study doctor and study sponsors. Additional Resources Clinical Trial Information. The results also "tell us that there are other things at play," he added, saying additional strategies were needed to fully combat Alzheimer's.

I think this safety profile matched with this efficacy profile is something that we can be excited about," Skovronsky said. Lilly said donanemab also showed positive results in the trial's secondary endpoints measuring cognition and function, but did not reach statistical significance on all of them.

Lilly, along with companies like Biogen Inc and Eisai Co Ltd, is one of the last large drugmakers pursuing treatments for Alzheimer's — a disease that afflicts nearly 6 million Americans and millions more worldwide. The U. Food and Drug Administration is reviewing Biogen's application for aducanumab, which also targets amyloid plaques. Biogen said one of its two pivotal aducanumab studies showed a statistically significant benefit in slowing cognitive and functional decline, but a second trial missed that goal, showing benefit only for some patients who got a high dose for at least 10 months.

Lilly said full trial results would be presented at a future medical meeting and submitted for publication in a peer-reviewed clinical journal.



0コメント

  • 1000 / 1000